blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3277714

EP3277714 - IMMUNOASSAY FOR COLLAGEN TYPE VI SEQUENCE [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  25.02.2019
Database last updated on 18.01.2025
FormerRequest for examination was made
Status updated on  05.01.2018
FormerThe international publication has been made
Status updated on  13.09.2017
Most recent event   Tooltip16.02.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Nordic Bioscience A/S
Herlev Hovedgade 207
2730 Herlev / DK
[2018/06]
Inventor(s)01 / NEDERGAARD, Anders
Nannasgade 1 1
2200 København / DK
02 / SAND, Jannie Marie
Myrholmen 12
2760 Måløv / DK
03 / SUN, Shu
Birkhøjterrasserne 439C
3520 Farum / DK
04 / LEEMING, Diana Julie
Gammel strandvej 209D
3060 Espergaerde / DK
05 / HENRIKSEN, Kim
Dyrehavevej 74
3400 Hillerød / DK
 [2018/06]
Representative(s)Beck Greener LLP
Fulwood House
12 Fulwood Place
London WC1V 6HR / GB
[N/P]
Former [2018/06]Beck Greener
Fulwood House
12 Fulwood Place
London WC1V 6HR / GB
Application number, filing date16713440.231.03.2016
[2018/06]
WO2016EP57127
Priority number, dateGB2015000565401.04.2015         Original published format: GB 201505654
[2018/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016156526
Date:06.10.2016
Language:EN
[2016/40]
Type: A1 Application with search report 
No.:EP3277714
Date:07.02.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 06.10.2016 takes the place of the publication of the European patent application.
[2018/06]
Search report(s)International search report - published on:EP06.10.2016
ClassificationIPC:C07K16/18, G01N33/53
[2018/06]
CPC:
G01N33/6887 (EP,KR,US); G01N33/53 (CN,KR); C07K16/18 (EP,CN,KR,US);
C07K2317/34 (EP,CN,KR,US); G01N2333/78 (EP,US); G01N2800/042 (EP,US);
G01N2800/52 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/06]
TitleGerman:IMMUNOASSAY FÜR COLLAGEN-TYP-VI-SEQUENZ[2018/06]
English:IMMUNOASSAY FOR COLLAGEN TYPE VI SEQUENCE[2018/06]
French:DOSAGE IMMUNOLOGIQUE POUR SÉQUENCE DE COLLAGÈNE TYPE VI[2018/06]
Entry into regional phase13.09.2017National basic fee paid 
13.09.2017Designation fee(s) paid 
13.09.2017Examination fee paid 
Examination procedure13.09.2017Examination requested  [2018/06]
13.09.2017Date on which the examining division has become responsible
07.03.2018Amendment by applicant (claims and/or description)
28.02.2019Despatch of a communication from the examining division (Time limit: M04)
04.04.2019Reply to a communication from the examining division
06.12.2019Despatch of a communication from the examining division (Time limit: M04)
06.04.2020Reply to a communication from the examining division
13.10.2020Despatch of a communication from the examining division (Time limit: M06)
19.04.2021Reply to a communication from the examining division
Fees paidRenewal fee
07.02.2018Renewal fee patent year 03
08.01.2019Renewal fee patent year 04
02.01.2020Renewal fee patent year 05
28.01.2021Renewal fee patent year 06
02.03.2022Renewal fee patent year 07
14.02.2023Renewal fee patent year 08
16.02.2024Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XDI]  - AIGNER T; HAMBACH L; SODER S; SCHLOTZER-SCHREHARDT U; POSCHL E, "The C5 domain of Col6A3 is cleaved off from the Col6 fibrils immediately after secretion", BIOCHEM BIOPHYS RES COMMUN, (2002), vol. 290, pages 743 - 8, XP055272520 [XD] 1,3 * page 744, paragraph 2 * [I] 2,4-20,22,23

DOI:   http://dx.doi.org/10.1006/bbrc.2001.6227
 [XDI]  - S. R. LAMANDE ET AL, "The C5 Domain of the Collagen VI 3(VI) Chain Is Critical for Extracellular Microfibril Formation and Is Present in the Extracellular Matrix of Cultured Cells", JOURNAL OF BIOLOGICAL CHEMISTRY, US, (20060616), vol. 281, no. 24, doi:10.1074/jbc.M510192200, ISSN 0021-9258, pages 16607 - 16614, XP055272518 [XD] 1,3 * page 16608, column R * [I] 2,4-20,22

DOI:   http://dx.doi.org/10.1074/jbc.M510192200
 [A]  - JIYOUNG PARK ET AL, "Adipocyte-derived endotrophin promotes malignant tumor progression", JOURNAL OF CLINICAL INVESTIGATION, US, (20121008), vol. 122, no. 11, doi:10.1172/JCI63930, ISSN 0021-9738, pages 4243 - 4256, XP055272669 [A] 1-23 * figure 2a *

DOI:   http://dx.doi.org/10.1172/JCI63930
 [XP]  - SHU SUN ET AL, "Collagen Type III and VI Turnover in Response to Long-Term Immobilization", PLOS ONE, (20151207), vol. 10, no. 12, doi:10.1371/journal.pone.0144525, page e0144525, XP055272524 [XP] 1-16 * the whole document *

DOI:   http://dx.doi.org/10.1371/journal.pone.0144525
 [AP]  - JANNIE M B SAND ET AL, "Accelerated extracellular matrix turnover during exacerbations of COPD", RESPIRATORY RESEARCH, BIOMED CENTRAL LTD., LONDON, GB, (20150611), vol. 16, no. 1, doi:10.1186/S12931-015-0225-3, ISSN 1465-9921, page 69, XP021226688 [AP] 1-23 * the whole document *

DOI:   http://dx.doi.org/10.1186/s12931-015-0225-3
by applicantWO2010115749
    - AGRAWAL R; JAIN P, "Dikshit SN. Balaglitazone: a second generation peroxisome proliferator-activated receptor (PPAR) gamma (gamma) agonist", MINI REV MED CHEM, (201202), vol. 12, no. 2, pages 87 - 97
    - AIGNER T; HAMBACH L; SODER S; SCHLOTZER-SCHREHARDT U; POSCHL E, "The C5 domain of Col6A3 is cleaved off from the Col6 fibrils immediately after secretion", BIOCHEM BIOPHYS RES COMMUN, (2002), vol. 290, pages 743 - 8
    - ARMBRECHT G; BELAVY DL; GAST U ET AL., "Resistive vibration exercise attenuates bone and muscle atrophy in 56 days of bed rest: biochemical markers of bone metabolism", OSTEOPOROS INT, (2010), vol. 21, pages 597 - 607
    - ATKINSON JC; RUHL M; BECKER J; ACKERMANN R; SCHUPPAN D, "Collagen VI regulates normal and transformed mesenchymal cell proliferation in vitro", EXP CELL RES, (19961101), vol. 228, pages 283 - 291
    - BARASCUK N; GENOVESE F; LARSEN L; BYRJALSEN I; ZHENG Q; SUN S; HOSBOND S; POULSEN TS; DIEDERICHSEN A; JENSEN JM, "A MMP derived versican neo-epitope is elevated in plasma from patients with atherosclerotic heart disease", INT J CLIN EXP MED, (2013), vol. 6, pages 174 - 184
    - BARASCUK N; VEIDAL SS; LARSEN L ET AL., "A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen", CLIN BIOCHEM, (2010), vol. 43, pages 899 - 904
    - BEDOGNI G; BELLENTANI S; MIGLIOLI L; MASUTTI F; PASSALACQUA M; CASTIGLIONE A ET AL., "The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population", BMC GASTROENTEROL, (2006), vol. 6, page 33
    - BELAVY DL; MIOKOVIC T; ARMBRECHT G ET AL., "Resistive vibration exercise reduces lower limb muscle atrophy during 56-day bed-rest", JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS, (2009), vol. 9, pages 225 - 235
    - BERGER JP; AKIYAMA TE; MEINKE PT, "PPARs: therapeutic targets for metabolic disease", TRENDS PHARMACOL SCI, (200505), vol. 26, no. 5, pages 244 - 51
    - BHASIN S; HE EJ; KAWAKUBO M ET AL., "N-terminal propeptide of type III procollagen as a biomarker of anabolic response to recombinant human GH and testosterone", J CLIN ENDOCRINOL METAB, (2009), vol. 94, pages 4224 - 4233
    - BIDANSET DJ; GUIDRY C; ROSENBERG LC ET AL., "Binding of the proteoglycan decorin to collagen type VI", J BIOL CHEM, (1992), vol. 267, pages 5250 - 6
    - BONALDO P; RUSSO V; BUCCIOTTI F; DOLIANA R; COLOMBATTI A, "Structural and functional features of the alpha 3 chain indicate a bridging role for chicken collagen VI in connective tissues", BIOCHEMISTRY, (1990), vol. 29, pages 1245 - 54
    - BONALDO P; SANDRI M, "Cellular and molecular mechanisms of muscle atrophy", DIS MODEL MECH, (2012), vol. 6, pages 25 - 39
    - BURT AD; GRIFFITHS MR; SCHUPPAN D; VOSS B; MACSWEEN RN, "Ultrastructural localization of extracellular matrix proteins in liver biopsies using ultracryomicrotomy and immuno-gold labelling", HISTOPATHOLOGY, (199001), vol. 16, no. L, pages 53 - 8
    - BUSHBY KM; COLLINS J; HICKS D, "Collagen type VI myopathies", ADV EXP MED BIOL, (2014), vol. 802, pages 185 - 99
    - CARTER RI; UNGURS MJ; MUMFORD RA; STOCKLEY RA, "Aalpha-Val360: a marker of neutrophil elastase and COPD disease activity", EUR RESPIR J, (201301), vol. 41, pages 31 - 38
    - CHARBONNEL B; DEFRONZO R; DAVIDSON J; SCHMITZ 0; BIRKELAND K; PIRAGS V ET AL., "Pioglitazone use in combination with insulin in the prospective pioglitazone clinical trial in macrovascular events study (PROactivel9", J CLIN ENDOCRINOL METAB, (201005), vol. 95, no. 5, pages 2163 - 71
    - CHEN F; LAM R; SHAYWITZ D ET AL., "Evaluation of early biomarkers of muscle anabolic response to testosterone", J CACHEXIA SARCOPENIA MUSCLE, (2011), vol. 2, pages 45 - 56
    - CHO N; MOMOSE Y, "Peroxisome proliferator-activated receptor gamma agonists as insulin sensitizers: from the discovery to recent progress", CURR TOP MED CHEM, (2008), vol. 8, no. 17, pages 1483 - 507
    - CORHAY JL; MOERMANS C; HENKET M; NGUYEN DD; DUYSINX B; LOUIS R, "Increased of exhaled breath condensate neutrophil chemotaxis in acute exacerbation of COPD", RESPIR RES, (2014), vol. 15, page 115
    - COX TR; ERLER JT, "Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer", DIS MODEL MECH, (201103), vol. 4, pages 165 - 178
    - CRUZ-JENTOFT AJ; BAEYENS JP; BAUER JM ET AL., "Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People", AGE AGEING, (2010), vol. 39, pages 412 - 23
    - DANKEL SN; SVARD J; MATTHA S; CLAUSSNITZER M; KLOTING N; GLUNK V ET AL., "COL6A3 expression in adipocytes associates with insulin resistance and depends on PPARgamma and adipocyte size", OBESITY, (201408), vol. 22, no. 8, pages 1807 - 13
    - DONALDSON GC; SEEMUNGAL TA; BHOWMIK A; WEDZICHA JA, "Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease", THORAX, (200210), vol. 57, pages 847 - 852
    - DONALDSON GC; WEDZICHA JA, "COPD exacerbations .1: Epidemiology", THORAX, (200602), vol. 61, pages 164 - 168
    - ENGVALL E; HESSLE H; KLIER G, "Molecular assembly, secretion, and matrix deposition of type VI collagen", J CELL BIOL, (198603), vol. 102, pages 703 - 710
    - FEIGH M; HENRIKSEN K; ANDREASSEN KV; HANSEN C; HENRIKSEN JE; BECK-NIELSEN H ET AL., "A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet-induced obese rats", DIABETES OBES METAB, (201110), vol. 13, no. 10, pages 911 - 20
    - GEFTER ML; MARGULIES DH; SCHARFF MD, "A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells", SOMATIC CELL GENET, (1977), vol. 3, pages 231 - 6
    - GELSE K; POSCHL E; AIGNER T, "Collagens--structure, function, and biosynthesis", ADV DRUG DELIV REV, (2003), vol. 55, pages 1531 - 46
    - GIANNELLI G; DE MA; MARINOSCI F; ANTONACI S, "Matrix metalloproteinase imbalance in muscle disuse atrophy", HISTOL HISTOPATHOL, (2005), vol. 20, pages 99 - 106
    - GLOBAL STRATEGY FOR THE DIAGNOSIS, MANAGEMENT AND PREVENTION OF COPD, (201401), URL: www.goldcopd.org.
    - GRANZIER HL; IRVING TC, "Passive tension in cardiac muscle: contribution of collagen, titin, microtubules, and intermediate filaments", BIOPHYS J, (1995), vol. 68, pages 1027 - 44
    - GRIFFITHS MR; SHEPHERD M; FERRIER R; SCHUPPAN D; JAMES OF; BURT AD, "Light microscopic and ultrastructural distribution of type VI collagen in human liver: alterations in chronic biliary disease", HISTOPATHOLOGY, (199210), vol. 21, no. 4, pages 335 - 44
    - HALLGREN 0; NIHLBERG K; DAHLBACK M; BJERMER L, ERIKSSON LT; ERJEFALT JS; LOFDAHL CG; WESTERGREN-THORSSON G, "Altered fibroblast proteoglycan production in COPD", RESPIR RES, (2010), vol. 11, page 55
    - HEINEMEIER KM; OLESEN JL; HADDAD F ET AL., "Effect of unloading followed by reloading on expression of collagen and related growth factors in rat tendon and muscle", J APPL PHYSIOL, (2009), vol. 106, pages 178 - 186
    - HENRIKSEN K; BYRJALSEN I; QVIST P; BECK-NIELSEN H; HANSEN G; RIIS BJ ET AL., "Efficacy and safety of the PPARgamma partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy", DIABETES METAB RES REV, (201105), vol. 27, no. 4, pages 392 - 401
    - HOME PD; POCOCK SJ; BECK-NIELSEN H; CURTIS PS; GOMIS R; HANEFELD M ET AL., "Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial", LANCET, (20090620), vol. 373, no. 9681, pages 2125 - 35
    - HORTOBAGYI T; DEMPSEY L; FRASER D ET AL., "Changes in muscle strength, muscle fibre size and myofibrillar gene expression after immobilization and retraining in humans", J PHYSIOL, (2000), vol. 524, pages 293 - 304
    - HUANG R; MERRILEES MJ; BRAUN K; BEAUMONT B; LEMIRE J; CLOWES AW; HINEK A; WIGHT TN, "Inhibition of versican synthesis by antisense alters smooth muscle cell phenotype and induces elastic fiber formation in vitro and in neointima after vessel injury", CIRC RES, (20060217), vol. 98, pages 370 - 377
    - HUGHES VA; FRONTERA WR; ROUBENOFF R; EVANS WJ; SINGH MA, "Longitudinal changes in body composition in older men and women: role of body weight change and physical activity", AM J CLIN NUTR, (2002), vol. 76, pages 473 - 81
    - HURST JR; VESTBO J; ANZUETO A; LOCANTORE N; MULLEROVA H; TAL-SINGER R; MILLER B; LOMAS DA; AGUSTI A; MACNEE W, "Susceptibility to exacerbation in chronic obstructive pulmonary disease", N ENGL J MED, (20100916), vol. 363, pages 1128 - 1138
    - KARALLIEDDE J; BUCKINGHAM RE, "Thiazolidinediones and their fluid-related adverse effects: facts, fiction and putative management strategies", DRUG SAF, (2007), vol. 30, no. 9, pages 741 - 53
    - KARSDAL MA; DELVIN E; CHRISTIANSEN C, "Protein fingerprints - relying on and understanding the information of serological protein measurements", CLIN BIOCHEM, (201111), vol. 44, pages 1278 - 1279
    - KARSDAL MA; MANON-JENSEN T; GENOVESE F; KRISTENSEN JH; NIELSEN MJ; SAND JM ET AL., "Novel insights into the function and dynamics of extracellular matrix in liver fibrosis", AM J PHYSIOL GASTROINTEST LIVER PHYSIOL, (20150515), vol. 308, no. 10, pages G807 - G830
    - KARSDAL MA; NIELSEN MJ; SAND JM; HENRIKSEN K; GENOVESE F; BAY-JENSEN AC; SMITH V; ADAMKEWICZ JI; CHRISTIANSEN C; LEEMING DJ, "Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure", ASSAY DRUG DEV TECHNOL, (201303), vol. 11, pages 70 - 92
    - KEENE DR; ENGVALL E; GLANVILLE RW, "Ultrastructure of type VI collagen in human skin and cartilage suggests an anchoring function for this filamentous network", J CELL BIOL, (1988), vol. 107, pages 1995 - 2006
    - KENAGY RD; PLAAS AH; WIGHT TN, "Versican degradation and vascular disease", TRENDS CARDIOVASC MED, (200608), vol. 16, pages 209 - 215
    - KHAN T; MUISE ES; IYENGAR P; WANG ZV; CHANDALIA M; ABATE N, "al. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI", MOL CELL BIOL, (200903), vol. 29, no. 6, pages 1575 - 91
    - KUO HJ; MASLEN CL; KEENE DR; GLANVILLE RW, "Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen", J BIOL CHEM, (1997), vol. 272, pages 26522 - 9
    - LAMANDE SR; MORGELIN M; ADAMS NE; SELAN C; ALLEN JM, "The C5 domain of the collagen VI alpha3(VI) chain is critical for extracellular microfibril formation and is present in the extracellular matrix of cultured cells", J BIOL CHEM, (2006), vol. 281, pages 16607 - 14
    - LAMPE AK; BUSHBY KMD, "Collagen VI related muscle disorders", J MED GENET, (2005), vol. 42, pages 673 - 685
    - LARSEN PJ; LYKKEGAARD K; LARSEN LK; FLECKNER J; SAUERBERG P; WASSERMANN K ET AL., "Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-gamma) agonist balaglitazone", EUR J PHARMACOL, (20081031), vol. 596, no. 1-3, pages 173 - 9
    - LEBENSZTEJN DM; SOBANIEC-LOTOWSKA ME; KACZMARSKI M; VOELKER M; SCHUPPAN D, "Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha", WORLD J GASTROENTEROL, (20060607), vol. 12, no. 21, pages 3338 - 43
    - LEEMING DJ; NIELSEN MJ; DAI Y; VEIDAL SS; VASSILIADIS E; ZHANG C; HE Y; VAINER B; ZHENG Q; KARSDAL MA, "Enzyme-linked immunosorbent serum assay specific for the 7S domain of Collagen Type IV (P4NP 7S): A marker related to the extracellular matrix remodeling during liver fibrogenesis", HEPATOL RES, (201205), vol. 42, pages 482 - 493
    - LEEMING DJ; SAND JM; NIELSEN MJ; GENOVESE F; MARTINEZ FJ; HOGABOAM CM; HAN MK; KLICKSTEIN LB; KARSDAL MA, "Serological investigation of the collagen degradation profile of patients with chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis", BIOMARK INSIGHTS, (2012), vol. 7, pages 119 - 126
    - LEEMING DJ; KARSDAL MA; BYRJALSEN I; BENDTSEN F; TREBICKA J; NIELSEN MJ ET AL., "Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension", ALIMENT PHARMACOL THER, (201311), vol. 38, no. 9, pages 1086 - 96
    - MAK KM; SEHGAL P; HARRIS CK, "Type VI Collagen: Its Biology and Value as a Biomarker of Hepatic Fibrosis", AUSTIN BIOMARK DIAGN., (2014), vol. 1, no. 2, page 9
    - MERCER PF; SHUTE JK; BHOWMIK A; DONALDSON GC; WEDZICHA JA; WARNER JA, "MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation", RESPIR RES, (2005), vol. 6, page 151
    - MERRILEES MJ; CHING PS; BEAUMONT B; HINEK A; WIGHT TN; BLACK PN, "Changes in elastin, elastin binding protein and versican in alveoli in chronic obstructive pulmonary disease", RESPIR RES, (2008), vol. 9, page 41
    - MILLER BF; OLESEN JL; HANSEN M ET AL., "Coordinated collagen and muscle protein synthesis in human patella tendon and quadriceps muscle after exercise", J PHYSIOL (LOND, (2005), vol. 567, pages 1021 - 1033
    - MILLER TA; LESNIEWSKI LA; MULLER-DELP JM ET AL., "Hindlimb unloading induces a collagen isoform shift in the soleus muscle of the rat", AJP: REGULATORY, INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, (2001), vol. 281, pages R1710 - R1717
    - NEDERGAARD A; KARSDAL MA; SUN S; HENRIKSEN K, "Serological muscle loss biomarkers: an overview of current concepts and future possibilities", J CACHEXIA SARCOPENIA MUSCLE, (2013), vol. 4, pages 1 - 17
    - NEDERGAARD A; SUN S; KARSDAL MA ET AL., "Type VI collagen turnover-related peptides-novel serological biomarkers of muscle mass and anabolic response to loading in young men", J CACHEXIA SARCOPENIA MUSCLE, (2013), vol. 4, pages 267 - 275
    - NIELSEN MJ; NEDERGAARD AF; SUN S ET AL., "The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters", AM J TRANSL RES, (2013), vol. 5, pages 303 - 315
    - NIEMELA 0; RISTELI L; PARKKINEN J; RISTELI J, "Purification and characterization of the N-terminal propeptide of human type III procollagen", BIOCHEM J, (1985), vol. 232, pages 145 - 50
    - O'REILLY PJ; JACKSON PL; WELLS JM; DRANSFIELD MT; SCANLON PD; BLALOCK JE, "Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations", BMJ OPEN, (2013), vol. 3, page E004140
    - ORKIN RW; GEHRON P; MCGOODWIN EB; MARTIN GR; VALENTINE T; SWARM R, "A murine tumor producing a matrix of basement membrane", J EXP MED, (19770101), vol. 145, pages 204 - 220
    - PASARICA M; GOWRONSKA-KOZAK B; BURK D; REMEDIOS I; HYMEL D; GIMBLE J ET AL., "Adipose tissue collagen VI in obesity", J CLIN ENDOCRINOL METAB, (200912), vol. 94, no. 12, pages 5155 - 62
    - PARK J; SCHERER PE, "Adipocyte-derived endotrophin promotes malignant tumor progression", J CLIN INVEST, (201211), vol. 122, no. 11, pages 4243 - 56
    - PARK J; SCHERER PE, "Endotrophin in the tumor stroma: a new therapeutic target for breast cancer?", EXPERT REV ANTICANCER THER, (201302), vol. 13, no. 2, pages 111 - 3
    - PFISTER RR; HADDOX JL; SOMMERS CI; LAM KW, "Identification and synthesis of chemotactic tripeptides from alkali-degraded whole cornea. A study of N-acetyl-proline-glycine-proline and N-methyl-proline-glycine-proline", INVEST OPHTHALMOL VIS SCI, (199506), vol. 36, pages 1306 - 1316
    - RENNIE MJ; SELBY A; ATHERTON P ET AL., "Facts, noise and wishful thinking: muscle protein turnover in aging and human disuse atrophy", SCAND J MED SCI SPORTS, (2010), vol. 20, pages 5 - 9
    - REZNICK AZ; MENASHE 0; BAR-SHAI M; COLEMAN R; CARMELI E, "Expression of matrix metalloproteinases, inhibitor, and acid phosphatase in muscles of immobilized hindlimbs of rats", MUSCLE NERVE, (2003), vol. 27, pages 51 - 9
    - RITTWEGER J; BELAVY D; HUNEK P ET AL., "Highly demanding resistive vibration exercise program is tolerated during 56 days of strict bed-rest", INT J SPORTS MED, (2006), vol. 27, pages 553 - 9
    - RUHL M; JOHANNSEN M; ATKINSON J; MANSKI D; SAHIN E; SOMASUNDARAM R; RIECKEN EO; SCHUPPAN D, "Soluble collagen VI induces tyrosine phosphorylation of paxillin and focal adhesion kinase and activates the MAP kinase erk2 in fibroblasts", EXP CELL RES, (19990801), vol. 250, pages 548 - 557
    - RUHL M; SAHIN E; JOHANNSEN M; SOMASUNDARAM R; MANSKI D; RIECKEN EO; SCHUPPAN D, "Soluble collagen VI drives serum-starved fibroblasts through S phase and prevents apoptosis via down-regulation of Bax", J BIOL CHEM, (19991126), vol. 274, pages 34361 - 34368
    - SAND JM; LARSEN L; HOGABOAM C; MARTINEZ F; HAN M; ROSSEL LM; NAWROCKI A; ZHENG Q; KARSDAL MA; LEEMING DJ, "MMP mediated degradation of type IV collagen alpha 1 and alpha 3 chains reflects basement membrane remodeling in experimental and clinical fibrosis--validation of two novel biomarker assays", PLOS ONE, (2013), vol. 8, page E84934
    - SAVOLAINEN J; VAANANEN K; VIHKO V ET AL., "Effect of immobilization on collagen synthesis in rat skeletal muscles", AMERICAN JOURNAL OF PHYSIOLOGY - REGULATORY, INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, (1987), vol. 252, pages R883 - R888
    - SCHARF G; HEINEKE J, "Finding good biomarkers for sarcopenia", J CACHEXIA SARCOPENIA MUSCLE, (2012), vol. 3, pages 145 - 8
    - SEEMUNGAL TA; DONALDSON GC; PAUL EA; BESTALL JC; JEFFRIES DJ; WEDZICHA JA, "Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease", AM J RESPIR CRIT CARE MED, (199805), vol. 157, pages 1418 - 1422
    - SOLER-CATALUNA JJ; MARTINEZ-GARCIA MA; ROMAN SP; SALCEDO E; NAVARRO M; OCHANDO R, "Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease", THORAX, (200511), vol. 60, pages 925 - 931
    - SOROCEANU MA; MIAO D; BAI XY; SU H; GOLTZMAN D; KARAPLIS AC, "Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis", J ENDOCRINOL, (200410), vol. 183, no. 1, pages 203 - 16
    - STALLCUP WB; DAHLIN K; HEALY P, "Interaction of the NG2 chondroitin sulfate proteoglycan with type VI collagen", J CELL BIOL, (1990), vol. 111, pages 3177 - 88
    - STICKEL F; URBASCHEK R; SCHUPPAN D; POESCHL G; OESTERLING C; CONRADT C ET AL., "Serum collagen type VI and XIV and hyaluronic acid as early indicators for altered connective tissue turnover in alcoholic liver disease", DIG DIS SCI, (200109), vol. 46, no. 9, pages 2025 - 32
    - SUN K; PARK J; GUPTA OT; HOLLAND WL; AUERBACH P; ZHANG N ET AL., "Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction", NAT COMMUN, (2014), vol. 5, page 3485
    - TAKADA I; SUZAWA M; MATSUMOTO K; KATO S., "Suppression of PPAR transactivation switches cell fate of bone marrow stem cells from adipocytes into osteoblasts", ANN N Y ACAD SCI, (200711), vol. 1116, pages 182 - 95
    - TAKAMATSU S; NAKABAYASHI H; OKAMOTO Y; NAKANO H, "Noninvasive determination of liver collagen content in chronic hepatitis. Multivariate regression modeling with blood chemical parameters as variables", J GASTROENTEROL, (199706), vol. 32, pages 355 - 360
    - TAPANAINEN P; KNIP M; RISTELI L ET AL., "Collagen metabolites in the prediction of response to GH therapy in short children", EUR J ENDOCRINOL, (1997), vol. 137, pages 621 - 625
    - TETLEY TD., "Inflammatory cells and chronic obstructive pulmonary disease", CURR DRUG TARGETS INFLAMM ALLERGY, (200512), vol. 4, pages 607 - 618
    - URCIUOLO A; QUARTA M; MORBIDONI V ET AL., "Collagen VI regulates satellite cell self-renewal and muscle regeneration", NAT COMMUN 4, (2013), vol. 1964, page 4
    - VEIDAL SS; KARSDAL MA; VASSILIADIS E ET AL., "MMP mediated degradation of type VI collagen is highly associated with liver fibrosis--identification and validation of a novel biochemical marker assay", PLOS ONE, (2011), vol. 6, page E24753
    - VESTBO J; RENNARD S., "Chronic obstructive pulmonary disease biomarker(s) for disease activity needed--urgently", AM J RESPIR CRIT CARE MED, (20101001), vol. 182, pages 863 - 864
    - WELLE S., "Cellular and molecular basis of age-related sarcopenia", CAN J APPL PHYSIOL, (2002), vol. 27, pages 19 - 41
    - WILLIAMS P; GOLDSPINK G, "Connective tissue changes in surgically overloaded muscle", CELL TISSUE RES, (1981), vol. 221, pages 465 - 470
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.